InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,949.17
(
-0.60%
)
US TECH 100
20,347.60
(
0.00%
)
Dow Jones
43,750.86
(
-0.47%
)
Brent Oil
71.64
(
-0.80%
)
Bitcoin
88,171.45
(
0.95%
)
Post# of 253608
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

masterlongevity

Send PM Follow Ignore
Followers 25
Posts 2597
Boards Moderated 0
Alias Born 01/07/2004

masterlongevity

Re: DewDiligence post# 110676

Sunday, 12/12/2010 12:56:03 PM

Sunday, December 12, 2010 12:56:03 PM

Post# of 253608
i agree with you and do think this is a very notable development. i know there have been small incontolled investigator run trials where combo monoclonals with chemo have looked good, but this is the 1st large well controlled trial i am aware of.


i sent over nice congrats email to the clinician and regulatory affairs person at Genentech who have been working on the pertuzumab project for yrs. It has taken backseat to other oncology development programs there for yrs, until recently.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up